Outlook BLISSful For HGS' Benlysta After Full Data Released At ACR

PHILADELPHIA - The full data set for Human Genome Sciences' pivotal BLISS-52 study - presented at the American College of Rheumatology meeting on Oct. 20 - gives some indication that the firm's systemic lupus erythematosus candidate Benlysta (belimumab) could have a broader than expected commercial reach